TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33902656

Group type: EXPERIMENTAL
Intervention: Telemonitoring system (OPTIMUM)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 330
Study: 32459420

Group type: EXPERIMENTAL
Intervention: 5 mg of oral dronabinol
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 33220297

Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Endorectal formalin instillation (EFI)
Number of subjects: 27
Study: 32390547

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF)
Number of subjects: 1692157

Group type: EXPERIMENTAL
Intervention: AF associated with SND
Number of subjects: 1692157

Group type: EXPERIMENTAL
Intervention: Isolated sinus node disease (SND)
Number of subjects: 1692157

Group type: COMPARATOR
Intervention: Control population with other cardiac conditions
Number of subjects: 1692157

Group type: EXPERIMENTAL
Intervention: SND compared to AF
Number of subjects: 1692157

Group type: EXPERIMENTAL
Intervention: SND compared to control population
Number of subjects: 1692157
Study: 36286852

Group type: EXPERIMENTAL
Intervention: Brainmax
Number of subjects: 180

Group type: COMPARATOR
Intervention: ethylmethylhydroxypyridine succinate
Number of subjects: 180

Group type: COMPARATOR
Intervention: trimethylhydrazinium propionate
Number of subjects: 180
Study: 33682194

Group type: EXPERIMENTAL
Intervention: 8-week training session on hand hygiene for children and an education program for parents (seminar and WeChat groups)
Number of subjects: 582

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 582
Study: 35224756

Group type: EXPERIMENTAL
Intervention: Fusobacterium nucleatum (Fn) and Lachnoclostridium marker (m3)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Clostridium hathewayi (Ch)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Combination of m3, Fn and Ch at follow-up
Number of subjects: 161

Group type: COMPARATOR
Intervention: Faecal immunochemical test (FIT)
Number of subjects: 161
Study: 34119499

Group type: COMPARATOR
Intervention: Prophylactic cefazolin 2 g IV (Group A)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Prophylaxis + cefazolin 2 g IV × 3 followed by oral amoxicillin/clavulanate 3 g/day (Group B)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Group A (Prophylactic cefazolin 2 g IV)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Group B (Prophylaxis + cefazolin 2 g IV × 3 followed by oral amoxicillin/clavulanate 3 g/day)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 124
Study: 32293191

Group type: EXPERIMENTAL
Intervention: Mid-position (Mid‐p) strategy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Internal target volume (ITV) strategy
Number of subjects: 44
Study: 36053803

Group type: EXPERIMENTAL
Intervention: Albiglutide
Number of subjects: 9462

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9462
Study: 33491424

Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus (GDM) patients
Number of subjects: 110

Group type: COMPARATOR
Intervention: Normal pregnant women (comparison group)
Number of subjects: 110
Study: 34846805

Group type: EXPERIMENTAL
Intervention: Digital medical history (DMH) implementation
Number of subjects: 640

Group type: COMPARATOR
Intervention: Phone calls for DMH completion
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Age and anatomic injury location
Number of subjects: 640
Study: 34002562

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham Electroacupuncture (sham EA)
Number of subjects: 60
Study: 32779728

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 200 mg daily for 7 days
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo (0.9% saline) for 7 days
Number of subjects: 1000
Study: 35724252

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33483447

Group type: EXPERIMENTAL
Intervention: Tourniquet inflated
Number of subjects: 53

Group type: COMPARATOR
Intervention: Tourniquet not inflated
Number of subjects: 53
Study: 35490404

Group type: EXPERIMENTAL
Intervention: BAY 1831865 (3.5, 7, 17, 35, 75, or 150 mg i.v. or 150 mg s.c.)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: BAY 1831865 i.v.
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: BAY 1831865 s.c.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 33321441

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 every 3 weeks)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 504

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 504
Study: 32833918

Group type: EXPERIMENTAL
Intervention: Knowledge score
Number of subjects: 11657

Group type: EXPERIMENTAL
Intervention: Awareness
Number of subjects: 11657
Study: 34657999

Group type: EXPERIMENTAL
Intervention: Individually set training threshold
Number of subjects: 36

Group type: COMPARATOR
Intervention: Group averaged training threshold
Number of subjects: 36
Study: 34028131

Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Contingency Management (CM)
Number of subjects: 0
Study: 32060679

Group type: EXPERIMENTAL
Intervention: Wheat hot pack (WHP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pottery hot pack (PHP)
Number of subjects: 30
Study: 36179382

Group type: EXPERIMENTAL
Intervention: Controlling and emotional IPV
Number of subjects: 3086

Group type: EXPERIMENTAL
Intervention: Material hardship
Number of subjects: 3086
Study: 32084041

Group type: EXPERIMENTAL
Intervention: Family management style combined with routine care
Number of subjects: 130

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Family management style
Number of subjects: 130
Study: 33905902

Group type: COMPARATOR
Intervention: Combined administration of 2% lidocaine and 0.5% bupivacaine (20 mL mixture: 10 mL each)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Sequential administration of 2% lidocaine (10 mL) followed by 0.5% bupivacaine (10 mL) after 120 s
Number of subjects: 97

Group type: COMPARATOR
Intervention: Combined administration of 2% lidocaine and 0.5% bupivacaine
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Sequential administration of 2% lidocaine and 0.5% bupivacaine
Number of subjects: 97
Study: 34882430

Group type: EXPERIMENTAL
Intervention: ICD group
Number of subjects: 1116
Study: 32438624

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii CNCM I‐1079
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 34001185

Group type: EXPERIMENTAL
Intervention: Fast track clinical pathway
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard care protocol
Number of subjects: 90
Study: 32065258

Group type: EXPERIMENTAL
Intervention: 5-min stair climbing every hour during a 4-h sitting period
Number of subjects: 12

Group type: COMPARATOR
Intervention: 4-h uninterrupted sitting
Number of subjects: 12
Study: 34813038

Group type: EXPERIMENTAL
Intervention: Closure of mesenteric defects (n=150)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Nonclosure of mesenteric defects (n=150)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Total radiation dose in closure group
Number of subjects: 300

Group type: COMPARATOR
Intervention: Total radiation dose in nonclosure group
Number of subjects: 300
Study: 32193692

Group type: EXPERIMENTAL
Intervention: Lower physical activity level
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Lower age
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Physical activity level and age
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Lymph‐ICF‐UL questionnaire
Number of subjects: 185
Study: 34210209

Group type: EXPERIMENTAL
Intervention: Light gradient boosting machines prediction model
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Cases of ICP
Number of subjects: 487

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 487
Study: 34839603

Group type: EXPERIMENTAL
Intervention: Artificial dermis+split-thickness skin
Number of subjects: 82

Group type: COMPARATOR
Intervention: Flap
Number of subjects: 82
Study: 36220325

Group type: EXPERIMENTAL
Intervention: Experimental therapeutics (specifics not provided)
Number of subjects: 20
Study: 33811400

Group type: EXPERIMENTAL
Intervention: 1% phytic acid solution and AH Plus sealer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1% phytic acid solution and EndoSequence BC sealer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 17% EDTA solution and AH Plus sealer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 17% EDTA solution and EndoSequence BC sealer
Number of subjects: 40
Study: 32251400

Group type: EXPERIMENTAL
Intervention: Ipilimumab plus Nivolumab (20 dMMR tumors)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ipilimumab plus Nivolumab (15 pMMR tumors)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nivolumab monotherapy (3 patients in safety run-in)
Number of subjects: 40
Study: 34060166

Group type: EXPERIMENTAL
Intervention: Lidocaine cream
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cutaneous stimulation therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 120
Study: 34410847

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 32365849

Group type: EXPERIMENTAL
Intervention: Perilla frutescens leaf powder (PLP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (pectin fiber)
Number of subjects: 60
Study: 36314372

Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange (TPE)
Number of subjects: 742

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 742
Study: 32636205

Group type: EXPERIMENTAL
Intervention: Receiving up to four bi‐weekly email reminders to translate PLSs
Number of subjects: 80

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 80
Study: 32118696

Group type: EXPERIMENTAL
Intervention: Chronic low-dose carbon monoxide (CO) administration
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 36042146

Group type: EXPERIMENTAL
Intervention: Targeted renal sympathetic denervation (RDN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 0
Study: 34399066

Group type: EXPERIMENTAL
Intervention: Spirulina supplementation (6 g/day for 21 days)
Number of subjects: 15
Study: 36000374

Group type: EXPERIMENTAL
Intervention: Vitamin A eye gel combined with 3M transparent tape
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Erythromycin eye ointment combined with 3M transparent tape
Number of subjects: 120
Study: 32232645

Group type: EXPERIMENTAL
Intervention: 3DMax™ mesh
Number of subjects: 48

Group type: COMPARATOR
Intervention: Ultrapro® mesh
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Robotic mesh placement
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: NASA-TLX self-assessment surveys
Number of subjects: 48
Study: 33310488

Group type: EXPERIMENTAL
Intervention: Mindfulness-induction
Number of subjects: 29

Group type: COMPARATOR
Intervention: Neutral-induction
Number of subjects: 29
Study: 32913021

Group type: EXPERIMENTAL
Intervention: 20 mg escitalopram × 2 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 20 mg escitalopram × 8 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 30 mg escitalopram × 8 weeks
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 35777494

Group type: EXPERIMENTAL
Intervention: Estradiol and progesterone addback for 8 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hormone withdrawal
Number of subjects: 30
Study: 32091593

Group type: EXPERIMENTAL
Intervention: Web-based menu-planning tool and support
Number of subjects: 522

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 522
Study: 36301305

Group type: EXPERIMENTAL
Intervention: Parent-Adolescent (PA) treatment condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parent-only condition
Number of subjects: 0
Study: 34663649

Group type: EXPERIMENTAL
Intervention: MALDI‐TOF mass spectrometry
Number of subjects: 5550

Group type: COMPARATOR
Intervention: Conventional methods of microbial identification
Number of subjects: 5550
Study: 32089456

Group type: EXPERIMENTAL
Intervention: LDL-C goal <50 mg/dL for all patients in secondary prevention or very high-risk primary prevention; optional goal ≤30 mg/dL for category A extreme-risk patients; recommended goal ≤30 mg/dL for category B extreme-risk patients.
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Use of statins and ezetimibe
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Proprotein convertase subtilisin kexin type 9 inhibitors
Number of subjects: 162
Study: 36397083

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA) and care prior to surgery, in addition to standard protocol.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CGA and care prior to surgery, in addition to standard protocol.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best known practice as stipulated by Swedish colorectal cancer treatment guidelines within an enhanced recovery after surgery (ERAS) setting.
Number of subjects: 0
Study: 32109221

Group type: EXPERIMENTAL
Intervention: Intravenous PCA with remifentanil
Number of subjects: 155

Group type: COMPARATOR
Intervention: Epidural analgesia with programmed intermittent bolus dosing
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 155
Study: 35603874

Group type: EXPERIMENTAL
Intervention: Correct handwashing training
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Correct mask-wearing training
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Training intervention
Number of subjects: 105
Study: 32799959

Group type: EXPERIMENTAL
Intervention: Organic food consumption
Number of subjects: 3896

Group type: COMPARATOR
Intervention: Control for confounding variables (socio-economic status, quality of diet, physical activity)
Number of subjects: 3896
Study: 35610265

Group type: EXPERIMENTAL
Intervention: Evening blue-depleted light environments (BDLE)
Number of subjects: 12
Study: 34133856

Group type: EXPERIMENTAL
Intervention: Tofacitinib (10 mg twice daily for up to 14 days)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo (twice daily for up to 14 days)
Number of subjects: 289
Study: 32631366

Group type: EXPERIMENTAL
Intervention: Point of purchase prompts (PPPs) displayed in intervention shops (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No point of purchase prompts in control shops (n = 15)
Number of subjects: 30
Study: 36008352

Group type: EXPERIMENTAL
Intervention: Fluid volume quartile 1 (89-882 ml)
Number of subjects: 4671

Group type: COMPARATOR
Intervention: Fluid volume quartile 4 (1258-2790 ml)
Number of subjects: 4671

Group type: EXPERIMENTAL
Intervention: Fluid administration of 1000 ml starting at least 1 hour before contrast injection and continuing for 6 hours
Number of subjects: 4671

Group type: EXPERIMENTAL
Intervention: Mean fluid volumes <964 ml
Number of subjects: 4671
Study: 34535488

Group type: EXPERIMENTAL
Intervention: Usual care plus activity monitor and customised education, motivation and support delivered via text messaging
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual care with activity monitor (active control)
Number of subjects: 180
Study: 36151537

Group type: EXPERIMENTAL
Intervention: Malaria prevention education (MPE)
Number of subjects: 0
Study: 34320864

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fluorouracil 1% cream
Number of subjects: 30
Study: 33892831

Group type: EXPERIMENTAL
Intervention: Buffered one percent lidocaine (3 mL including 0.3 mL of 8.4 percent sodium bicarbonate)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Unbuffered two percent lidocaine (3 mL)
Number of subjects: 25
Study: 34157578

Group type: EXPERIMENTAL
Intervention: 10 mg methotrexate (MTX) per week
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 32470924

Group type: EXPERIMENTAL
Intervention: NZBC extract (CurraNZ™) 300 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 616545791

Group type: EXPERIMENTAL
Intervention: TEXT ME intervention (text message-based intervention providing advice, motivation, information, and support)
Number of subjects: 50000
Study: 36329165

Group type: EXPERIMENTAL
Intervention: Fluorescein Angiography (FA) guided laser treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional laser treatment
Number of subjects: 30
Study: 33527192

Group type: EXPERIMENTAL
Intervention: Intraligamentary anesthesia (ILA)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional inferior alveolar nerve block (IANB)
Number of subjects: 72
Study: 33514869

Group type: EXPERIMENTAL
Intervention: Low-dose group (100 ml of Lactobacillus casei strain Shirota)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: High-dose group (200 ml of Lactobacillus casei strain Shirota)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Positive control group (100 ml of special drinks without active Lactobacillus casei)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Normal control group (20 healthy people)
Number of subjects: 158
Study: 34024606

Group type: EXPERIMENTAL
Intervention: Colostrum feeding at 12 h after birth (TRT12h)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Colostrum feeding at 45 min and 6 h after birth
Number of subjects: 22
Study: 32324471

Group type: EXPERIMENTAL
Intervention: Block-structured training alternating weekly between blood flow restricted low-load resistance training (BFR-RT) at 20% 1-RM and heavy-load resistance training (HL-RT) at 70-90% 1-RM (BFR-HRT, n = 9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Heavy-load resistance training (HL-RT, n = 9)
Number of subjects: 18
Study: 91343853

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35922444

Group type: EXPERIMENTAL
Intervention: midostaurin
Number of subjects: 475

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 475
Study: 35067831

Group type: EXPERIMENTAL
Intervention: Sauti ya Vijana (SYV) intervention
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 105
Study: 33534382

Group type: EXPERIMENTAL
Intervention: High limbal clearance scleral lenses
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low limbal clearance scleral lenses
Number of subjects: 22
Study: 32028486

Group type: EXPERIMENTAL
Intervention: POP repair with mesh
Number of subjects: 54194

Group type: COMPARATOR
Intervention: POP repair without transvaginal mesh (nonmesh)
Number of subjects: 54194

Group type: EXPERIMENTAL
Intervention: Reinterventions related to mesh complications
Number of subjects: 54194
Study: 35926074

Group type: EXPERIMENTAL
Intervention: Curated social web app for COVID-19 vaccine information
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Interviews with LTCWs (n=9)
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: LTCW poll (n=8)
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Community building efforts with LTCW ambassadors
Number of subjects: 592
Study: 33077275

Group type: EXPERIMENTAL
Intervention: High fibre flatbread with enzymatically released free FA (14.22 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Standard high fibre bread (2.34 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: White bread control (0.48 mg)
Number of subjects: 19
Study: 33169661

Group type: EXPERIMENTAL
Intervention: Dengue vaccine
Number of subjects: 10157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10157
Study: 33197654

Group type: EXPERIMENTAL
Intervention: Anodal tDCS at 2 mA for 20 min
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 32522124

Group type: EXPERIMENTAL
Intervention: Protein-rich gruel (atole)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonprotein, low-energy drink (fresco)
Number of subjects: 0
Study: 34489100

Group type: EXPERIMENTAL
Intervention: Collagen infiltrations (3-5 sessions)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment (Control Group)
Number of subjects: 15
Study: 33932397

Group type: EXPERIMENTAL
Intervention: Acute Intermittent Hypoxia (AIH)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham AIH
Number of subjects: 14
Study: 32119926

Group type: EXPERIMENTAL
Intervention: Peer-integrated collaborative care intervention
Number of subjects: 424

Group type: COMPARATOR
Intervention: Surgical team notification (enhanced usual care)
Number of subjects: 424
Study: 36204877

Group type: EXPERIMENTAL
Intervention: Ethanol injection combined with 125I radioactive seed implantation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ethanol injection alone
Number of subjects: 10
Study: 34259407

Group type: EXPERIMENTAL
Intervention: Jin's three‐needle combined with Tongdu Tiaoshen acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rehabilitation training and routine acupuncture
Number of subjects: 60
Study: 32183895

Group type: EXPERIMENTAL
Intervention: Ginger supplementation (dosage not specified)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (dosage not specified)
Number of subjects: 44
Study: 34655326

Group type: EXPERIMENTAL
Intervention: ECAU plus self‐guided CBT and SmartCare©
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ECAU plus SmartCare©
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combined intervention group (SmartCare© with or without CBT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: ECAU only
Number of subjects: 120
Study: 32485778

Group type: EXPERIMENTAL
Intervention: Whole-Body Electromyostimulation plus caloric restriction
Number of subjects: 25

Group type: COMPARATOR
Intervention: Caloric restriction alone
Number of subjects: 25
Study: 34936057

Group type: EXPERIMENTAL
Intervention: Pirfenidone 2403 mg/day
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253